This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

SILO Insider Trading

Insider Ownership Percentage: 5.56%
Insider Buying (Last 12 Months): $13,779.64
Insider Selling (Last 12 Months): $0.00

Silo Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Silo Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Silo Pharma Share Price & Price History

Current Price: $1.59
Price Change: Price Decrease of -0.03 (-1.85%)
As of 02/29/2024 06:18 PM ET

This chart shows the closing price history over time for SILO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.

Silo Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2023Eric WeisblumCEOBuy500$1.63$815.00169,724View SEC Filing Icon  
12/14/2023Eric WeisblumCEOBuy200$1.50$300.00168,324View SEC Filing Icon  
12/7/2023Eric WeisblumCEOBuy324$1.36$440.64168,124View SEC Filing Icon  
12/5/2023Eric WeisblumCEOBuy600$1.39$834.00167,724View SEC Filing Icon  
11/30/2023Eric WeisblumCEOBuy1,000$1.53$1,530.00167,124View SEC Filing Icon  
11/27/2023Eric WeisblumCEOBuy250$1.78$445.00165,124View SEC Filing Icon  
11/22/2023Eric WeisblumCEOBuy400$1.68$672.00164,874View SEC Filing Icon  
11/16/2023Eric WeisblumCEOBuy1,100$1.33$1,463.00158,324View SEC Filing Icon  
5/26/2023Daniel E RyweckCFOBuy1,000$2.13$2,130.005,000View SEC Filing Icon  
5/17/2023Eric WeisblumCEOBuy2,500$2.06$5,150.00157,224View SEC Filing Icon  
12/19/2022Eric WeisblumCEOBuy200$2.68$536.00154,724View SEC Filing Icon  
See Full Table
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.

SEC Filings (Institutional Ownership Changes) for Silo Pharma (NASDAQ:SILO)

3.22% of Silo Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SILO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Silo Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023State Street Corp12,500$26K0.0%N/A0.396%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC24,542$51K0.0%N/A0.777%Search for SEC Filing on Google Icon
5/11/2023Financial Advocates Investment Management44,507$93K0.0%+196.6%1.408%Search for SEC Filing on Google Icon
2/16/2023Financial Advocates Investment Management15,007$50K0.0%N/A0.478%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG6,799$37K0.0%N/A0.227%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Silo Pharma logo
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. The company's developing solutions to address various underserved conditions. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
Read More on Silo Pharma

Today's Range

Now: $1.59
Low: $1.44
High: $1.72

50 Day Range

MA: $1.51
Low: $1.36
High: $1.69

52 Week Range

Now: $1.59
Low: $1.22
High: $3.05

Volume

84,113 shs

Average Volume

124,991 shs

Market Capitalization

$4.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Silo Pharma?

Silo Pharma's top insider investors include:
  1. Eric Weisblum (CEO)
  2. Daniel E Ryweck (CFO)
Learn More about top insider investors at Silo Pharma.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.